Comparative Assessment of 2-Dimensional Echocardiography vs Cardiac Magnetic Resonance Imaging in Measuring Left Ventricular Mass in Patients With and Without End-Stage Renal Disease

Canadian Journal of Cardiology

Volumn 29, Issue 3, 2013, Pages 384-390

  Jakubovic, Baruch D ^a   Wald, Ron ^a,b   Goldstein, Marc B ^a,b   Leong Poi, Howard ^a,b   Yuen, Darren A ^a,b   Perl, Jeffrey ^a,b   Lima, Joao A ^c   Liu, Jerome J ^a   Kirpalani, Anish ^a,b   Dacouris, Niki ^b   Wald, Rachel ^a,d   Connelly, Kim A ^a,b   Yan, Andrew T ^a,b  

^a UNIVERSITY OF TORONTO   (Canada)

^b ST MICHAEL'S HOSPITAL   (Canada)

^c JOHNS HOPKINS UNIVERSITY   (United States)

^d UNIVERSITY HEALTH NETWORK   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTICLE; CARDIOVASCULAR MAGNETIC RESONANCE; CLINICAL ARTICLE; COMPARATIVE STUDY; FEMALE; HEART LEFT VENTRICLE HYPERTROPHY; HEART LEFT VENTRICLE MASS; HEART PAPILLARY MUSCLE; HEMODIALYSIS PATIENT; HUMAN; INTERMETHOD COMPARISON; KIDNEY FAILURE; KIDNEY FUNCTION; MALE; MUSCLE MASS; PREVALENCE; TWO DIMENSIONAL ECHOCARDIOGRAPHY; ULTRASOUND TRANSDUCER;

ADULT; ALGORITHMS; CROSS-SECTIONAL STUDIES; ECHOCARDIOGRAPHY; FEMALE; HEART VENTRICLES; HUMANS; HYPERTROPHY, LEFT VENTRICULAR; KIDNEY FAILURE, CHRONIC; MAGNETIC RESONANCE IMAGING, CINE; MALE; MIDDLE AGED; ONTARIO; PREVALENCE; RISK ASSESSMENT; RISK FACTORS;

EID: 84874340093     PISSN: 0828282X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cjca.2012.07.013     Document Type: Article

References (40)

1. Rostand S.G., Brunzell J.D., Cannon R.O., Victor R.G. Cardiovascular complications in renal failure. J Am Soc Nephrol 1991, 2:1053-1062.
2. Schietinger B.J., Brammer G.M., Wang H., et al. Patterns of late gadolinium enhancement in chronic hemodialysis patients. JACC Cardiovasc Imaging 2008, 1:450-456.
3. Mark P.B., Johnston N., Groenning B.A., et al. Redefinition of uremic cardiomyopathy by contrast-enhanced cardiac magnetic resonance imaging. Kidney Int 2006, 69:1839-1845.
4. Silberberg J.S., Barre P.E., Prichard S.S., Sniderman S.D. Impact of left ventricular hypertrophy on survival in end-stage renal disease. Kidney Int 1989, 36:286-290.
5. Glassock R.J., Pecoits-Filho R., Barbareto S. Increased left ventricular mass in chronic kidney disease and end-stage renal disease: what are the implications?. Dial Transplant 2010, 39:16-19.
6. Foley R.N., Parfrey P.S., Kent G.M., Harnett J.D., Murray D.C., Barre P.E. Serial change in echocardiographic parameters and cardiac failure in end-stage renal disease. J Am Soc Nephrol 2000, 11:912-916.
7. London G.M., Pannier B., Guerin A.P., et al. Alterations of left ventricular hypertrophy in and survival of patients receiving hemodialysis: follow-up of an interventional study. J Am Soc Nephrol 2001, 12:2759-2767.
8. Group F.H.N.T., Chertow G.M., Levin N.W., et al. In-center hemodialysis six times per week versus three times per week. N Engl J Med 2010, 363:2287-2300.
9. Culleton B.F., Walsh M., Klarenbach S.W., et al. Effect of frequent nocturnal hemodialysis vs conventional hemodialysis on left ventricular mass and quality of life: a randomized controlled trial. JAMA 2007, 298:1291-1299.
10. Devereux R.B., Reichek N. Echocardiographic determination of left ventricular mass in man: anatomic validation of the method. Circulation 1977, 55:613-618.
11. Devereux R.B., Alonso D.R., Lutas E.M. Echocardiographic assessment of left ventricular hypertrophy: comparison to necropsy findings. Am J Cardiol 1986, 57:450-458.
12. McLntyre C.W., Odudu A., Eldehni M.T. Cardiac assessment in chronic kidney disease. Curr Opin Nephrol Hypertens 2009, 18:501-506.
13. Foley R.N., Curtis B.M., Randell E.W., Parfrey P.S. Left ventricular hypertrophy in new hemodialysis patients without symptomatic cardiac disease. Clin J Am Soc Nephrol 2010, 5:805-813.
14. McGill R.L., Biederman R.W.W., Getts R.T., et al. Cardiac magnetic resonance imaging in hemodialysis patients. J Nephrol 2009, 22:367-372.
15. Constantine G., Shan K., Flamm S.D., Sivananthan M.U. Role of MRI in clinical cardiology. Lancet 2004, 363:2162-2171.
16. Lima J., Desai M. Cardiovascular magnetic resonance imaging: current and emerging applications. J Am Coll Cardiol 2004, 44:1164-1171.
17. Grothues F., Smith G.C., Moon J.C.C., et al. Comparison of interstudy reproducibility of cardiovascular magnetic resonance with two-dimensional echocardiography in normal subjects and in patients with heart failure or left ventricular hypertrophy. Am J Cardiol 2002, 90:29-34.
18. Bellenger N.G., Davies L.C., Francis J.M., Coats A.J., Pennell D.J. Reduction in sample size for studies of remodeling in heart failure by the use of cardiovascular magnetic resonance. J Cardiovasc Magn Reson 2000, 2:271-278.
19. Lang R.M., Bierig M., Devereux R.B., et al. Recommendations for chamber quantification: a report from the American Society of Echocardiography's guidelines and standards committee and the chamber quantification writing group, developed in conjunction with the European Association of Echocardiography, a branch of the European Society of Cardiology. J Am Soc Echocardiogr 2005, 18:1440-1463.
20. Hudsmith L.E., Petersen S.E., Francis J.M., Robson M.D., Neubauer S. Normal human left and right ventricular and left atrial dimensions using steady state free precession magnetic resonance imaging. J Cardiovasc Magn Reson 2005, 7:775-782.
21. Bellenger N.G., Grothues F., Smith G.C., Pennell D.J. Quantification of right and left ventricular function by cardiovascular magnetic resonance. Herz 2000, 25:392-399.
22. Bland J.M., Altman D.G. Statistical methods for assessing agreement between two methods of clinical measurement. Lancet 1986, 1:307-310.
23. McGinn T., Wyer P.C., Newman T.B., Keitz S., Leipzig R., Guyatt G. Tips for learners of evidence-based medicine: 3. Measures of observer variability (kappa statistic). CMAJ 2004, 171:1369-1373.
24. Rajappan K., Bellenger N.G., Melina G., et al. Assessment of left ventricular mass regression after aortic valve replacement-cardiovascular magnetic resonance versus M-mode echocardiography. Eur J Cardiothorac Surg 2003, 24:59-65.
25. Alfakih K., Plein S., Thiele H., Jones T., Ridgway J.P., Sivananthan M.U. Normal human left and right ventricular dimensions for MRI as assessed by turbo gradient echo and steady-state free precession imaging sequences. J Magn Reson Imaging 2003, 17:323-329.
26. Young A.A., Cowan B.R., Thrupp S.F., Hedley W.J., Dell'Italia L.J. Left ventricular mass and volume: fast calculation with guide-point modeling on mr images. Radiology 2000, 216:597-602.
27. van der Geest R.J., Buller V.G., Jansen E. Comparison between manual and semiautomated analysis of left ventricular volume parameters from short-axis MR images. J Comput Assist Tomogr 1997, 21:756-765. m-mode.
28. Vogel-Claussen J., Finn J.P., Gomes A.S., et al. Left ventricular papillary muscle mass: Relationship to left ventricular mass and volumes by magnetic resonance imaging. J Comput Assist Tomogr 2006, 30:426-432.
29. Stewart G.A., Foster J., Cowan M., et al. Echocardiography overestimates left ventricular mass in hemodialysis patients relative to magnetic resonance imaging. Kidney Int 1999, 56:2248-2253.
30. Missouris C.G., Forbat S.M., Singer D.R.J., Markandu N.D., Underwood R., MacGregor G.A. Echocardiography overestimates left ventricular mass: a comparative study with magnetic resonance imaging in patients with hypertension. J Hypertens 1996, 14:1005-1010.
31. Perdrix L., Mansencal N., Cocheteux B., et al. How to calculate left ventricular mass in routine practice?. An echocardiographic versus cardiac magnetic resonance study. Arch Cardiovasc Dis 2011, 104:343-351.
32. Myerson S.G., Montgomery H.E., World M.J., Pennell D.J. Left ventricular mass: reliability of M-mode and 2-dimensional echocardiographic formulas. Hypertension 2002, 40:673-678.
33. Nardi E., Palermo A., Mule G., Cusimano P., Cottone S., Cerasola G. Left ventricular hypertrophy and geometry in hypertensive patients with chronic kidney disease. J Hypertens 2009, 27:633-641.
34. Kilickap M., Turhan S., Sayin T., et al. Intravascular volume dependency of left ventricular mass calculation by two-dimensional guided M-mode echocardiography. Can J Cardiol 2007, 23:219-222.
35. Martin L.C., Barretti P., Cornejo I.V., et al. Influence of fluid volume variations on the calculated value of the left ventricular mass measured by echocardiogram in patients submitted to hemodialysis. Ren Fail 2003, 25:43-53.
36. Kilickap M., Turhan S., Sayin T., et al. Intravascular volume dependency of left ventricular mass calculation by two-dimensional guided M-mode echocardiography. Can J Cardiol 2007, 23:219-222.
37. Hunold P., Vogt F.M., Heemann U.W., Zimmermann U., Barkhausen J. Myocardial mass and volume measurement of hypertrophic left ventricles by MRI-study in dialysis patients examined before and after dialysis. J Cardiovasc Magn Reson 2003, 5:553-561.
38. Chuang M.L., Beaudin R.A., Riley M.F., et al. Three-dimensional echocardiographic measurement of left ventricular mass: comparison with magnetic resonance imaging and two-dimensional echocardiographic determinations in man. Int J Cardiovasc Imaging 2000, 16:347-357.
39. Hundley W.G., Bluemke D.A., Finn J.P., et al. ACCF/ACR/AHA/NASCI/SCMR 2010 expert consensus document on cardiovascular magnetic resonance: a report of the American College of Cardiology Foundation task force on expert consensus documents. Circulation 2010, 121:2462-2508.
40. Devereux R.B., Dahlof B., Gerdts E., et al. Regression of hypertensive left ventricular hypertrophy by losartan compared with atenolol: the Losartan Intervention for Endpoint Reduction in Hypertension (LIFE) trial. Circulation 2004, 110:1456-1462.